Skip to Main Content

Ranganathan Chosen to Receive National Alliance on Mental Illness 2022 Exemplary Psychiatrist Award

June 15, 2022

Mohini Ranganathan, MD, associate professor of psychiatry, has been selected to receive a 2022 National Alliance on Mental Illness (NAMI) 2022 Exemplary Psychiatrist Award.

The national award honors clinicians who “go the extra mile” and who have made substantial contributions to a NAMI Affiliate, NAMI State Organization or NAMI activities.

Award recipients are recognized for their advocacy for access to care and research funding, community education programs, or other NAMI priorities. Winners have also provided comprehensive treatment to people with mental illness including medical, rehabilitative and social needs or have taken the time to educate people whose lives are affected by mental illness.

Ranganathan is an outpatient psychiatrist at VA Connecticut Healthcare System, where she leads the Interventional Psychiatry/Treatment Refractory Depression Program, and a clinical researcher with a focus on cannabinoids (including Cannabidiol) and schizophrenia.

She is the principal investigator at Yale for a multi-site study supported by the Stanley Center at the Broad Institute aimed at developing a biorepository for the analyses of candidate fluid biomarkers in schizophrenia spectrum disorders. In this context she has collaborated with NAMI in the development of the study protocol and informational materials.

Submitted by Christopher Gardner on June 15, 2022